New Key Statistics Module, Z-Score and F-Score
OTCPK:PCHM Key Ratios
| Market Cap $ M | 12.08 |
| Enterprise Value $ M | 12.08 |
| P/E(ttm) | 59.09 |
| PE Ratio without NRI | 63.41 |
| Forward PE Ratio | -- |
| Price/Book | 5.10 |
| Price/Sales | 8.36 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 1.00 |
| EPS (TTM) $ | 0.04 |
| Beneish M-Score | -3.02 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -13.80 |
| EV-to-EBIT | 39.88 |
| EV-to-EBITDA | 39.88 |
| PEG | -- |
| Shares Outstanding M | 4.65 |
| Net Margin (%) | 14.26 |
| Operating Margin % | 19.37 |
| Pre-tax Margin (%) | 20.72 |
| Quick Ratio | 4.33 |
| Current Ratio | 4.76 |
| ROA % (ttm) | 6.86 |
| ROE % (ttm) | 8.68 |
| ROIC % (ttm) | 30.85 |
| Dividend Yield % | -- |
| Altman Z-Score | 12.37 |
PCHM Number of Guru Trades
PCHM Volume of Guru Trades
Gurus Latest Trades with OTCPK:PCHM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PCHM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
PharmChem Inc Insider Transactions
No Available Data
News about OTCPK:PCHM
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers